The drosperinone-containing oral contraceptives have a higher risk of thrombosis than the other combination products. Of course drosperinone also has advantages.
Should we not, in principle convert all patients to other combination products? Why should we ever even take the risk as a doctor?
China Reports First Commercial Brain-Computer Interface Implant for Spinal Cord Injury
Anatomy & Physiology
2h ago
56
Rare Triple Procedure Addresses Breast Cancer and Silent Cardiac Disease in One Operation
Cardiology
2h ago
51
Malnutrition from Womb to Tomb
Community Medicine
4h ago
1
India Adds Nearly 10,000 MBBS Seats for 2026 to 2027 Academic Session
Allergy & Immunology
9h ago
164
Climate Change Linked to Measurable Sleep Loss in India
Allergy & Immunology
1d ago
581
4
Haryana Detects Over 25,600 New TB Cases Through AI-Supported Screening Campaign
Anesthesiology
1d ago
212
3